BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12453673)

  • 1. Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.
    Small GW
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1561-6. PubMed ID: 12453673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-imaging surrogate markers for detection and prevention of age-related memory loss.
    Small GW
    J Mol Neurosci; 2002; 19(1-2):17-21. PubMed ID: 12212776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.
    Small GW
    J Clin Psychiatry; 1996; 57 Suppl 14():9-13. PubMed ID: 9024331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.
    Small GW; Komo S; La Rue A; Saxena S; Phelps ME; Mazziotta JC; Saunders AM; Haines JL; Pericak-Vance MA; Roses AD
    Ann N Y Acad Sci; 1996 Dec; 802():70-8. PubMed ID: 8993486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
    Small GW; Ercoli LM; Silverman DH; Huang SC; Komo S; Bookheimer SY; Lavretsky H; Miller K; Siddarth P; Rasgon NL; Mazziotta JC; Saxena S; Wu HM; Mega MS; Cummings JL; Saunders AM; Pericak-Vance MA; Roses AD; Barrio JR; Phelps ME
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6037-42. PubMed ID: 10811879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of brain activation in people at risk for Alzheimer's disease.
    Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
    N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging, subjective complaints, and MCI: 30 years before.
    Galluzzi S; Frisoni GB
    J Nutr Health Aging; 2008 Jan; 12(1):80S-3S. PubMed ID: 18165851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.
    Reiman EM; Caselli RJ; Chen K; Alexander GE; Bandy D; Frost J
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3334-9. PubMed ID: 11248079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory self-appraisal and depressive symptoms in people at genetic risk for Alzheimer's disease.
    Small GW; Chen ST; Komo S; Ercoli L; Miller K; Siddarth P; Kaplan A; Dorsey D; Lavretsky H; Saxena S; Bookheimer SY
    Int J Geriatr Psychiatry; 2001 Nov; 16(11):1071-7. PubMed ID: 11746653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
    Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
    Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.
    Rapoport SI
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5696-8. PubMed ID: 10811924
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease.
    Quevenco FC; Preti MG; van Bergen JM; Hua J; Wyss M; Li X; Schreiner SJ; Steininger SC; Meyer R; Meier IB; Brickman AM; Leh SE; Gietl AF; Buck A; Nitsch RM; Pruessmann KP; van Zijl PC; Hock C; Van De Ville D; Unschuld PG
    Alzheimers Res Ther; 2017 Mar; 9(1):24. PubMed ID: 28359293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.
    Small GW; Chen ST; Komo S; Ercoli L; Bookheimer S; Miller K; Lavretsky H; Saxena S; Kaplan A; Dorsey D; Scott WK; Saunders AM; Haines JL; Roses AD; Pericak-Vance MA
    Am J Psychiatry; 1999 Jul; 156(7):1035-8. PubMed ID: 10401448
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.